EpiVax will be presenting ‘Pathogen Camouflage: Implications for Vaccine Design’ at the Modern Vaccines Adjuvants Formulation (MVAF) taking place on 18-20 May 2016 in Copenhagen. MVAF 2016 will be the fifth meeting in this conference series and will offer an international forum for the discussion of all aspects of vaccine and adjuvant formulation. The conference will focus on:
- Innovation in vaccine design and adjuvantation/delivery technologies
- Challenges to manufacturing and the administration of modern vaccines
- Compliance with quality standards and regulatory requirements
MVAF 2016 will assess the impact of all of the above on the future development/design of vaccines and adjuvants. This conference is of interest to contributors from academic programs, industrial, governmental, regulatory and research groups.